Get the Stockscreener App
2.44
4.72%
0.11
Pre-market:
2.51
0.07
+2.87%
Adial Pharmaceuticals Inc stock is traded at $2.44, with a volume of 59,126.
It is up +4.72% in the last 24 hours and down -57.84% over the past month.
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
See More
Previous Close:
$2.33
Open:
$2.36
24h Volume:
59,126
Relative Volume:
2.17
Market Cap:
$2.71M
Revenue:
-
Net Income/Loss:
$-6.07M
P/E Ratio:
-0.4221
EPS:
-5.78
Net Cash Flow:
$-7.34M
1W Performance:
-9.63%
1M Performance:
-57.84%
6M Performance:
-74.32%
1Y Performance:
-87.24%
1-Day Range:
$2.27
$2.54
1-Week Range:
$2.27
$2.9128
52-Week Range:
$2.27
$32.50
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
Name
Adial Pharmaceuticals Inc
Sector
Industry
Phone
434-422-9800
Address
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Compare ADIL vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADIL
Adial Pharmaceuticals Inc
|
2.44 | 2.59M | 0 | -6.07M | -7.34M | -5.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
487.43 | 122.19B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
772.19 | 83.21B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
840.28 | 51.13B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
332.85 | 43.68B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
369.00 | 41.01B | 4.98B | 69.60M | 525.67M | 0.5198 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-30-18 | Initiated | Maxim Group | Buy |
| Oct-11-18 | Initiated | Dawson James | Buy |
Adial Pharmaceuticals Inc Stock (ADIL) Latest News
ARMISTICE CAPITAL, LLC Acquires Shares in Adial Pharmaceuticals Inc - GuruFocus
Key facts: Adial Pharmaceuticals meets Nasdaq bid requirement; advances AD04 to Phase 3 trial - TradingView
Adial Pharmaceuticals Regains Nasdaq Compliance, Advances AD04 Program - TipRanks
Adial Pharmaceuticals Regains Full Compliance with Nasdaq Listing Requirement - Bitget
Adial Pharmaceuticals regains full compliance with Nasdaq listing requirement - marketscreener.com
Adial Regains Nasdaq Compliance as AD04 Advances, Engages in Partnering Talks - TradingView
Adial Pharmaceuticals eyes single pivotal trial path for AD04 - Investing.com India
Adial Pharmaceuticals eyes single pivotal trial path for AD04 By Investing.com - Investing.com Australia
Adial Pharmaceuticals Highlights FDA Policy Direction That May Reduce Pivotal Trial Burden from Two Studies to One - Bitget
Adial Pharmaceuticals stock rises on FDA policy shift - Investing.com
Adial Pharmaceuticals stock rises on FDA policy shift By Investing.com - Investing.com UK
Adial Pharmaceuticals (ADIL) Sees Potential in FDA's New Approva - GuruFocus
New FDA trial policy could speed addiction drug for heavy drinkers - Stock Titan
Portfolio Shifts: Can Adial Pharmaceuticals Inc outperform under higher oil pricesJuly 2025 Volume & Consistent Profit Alerts - baoquankhu1.vn
Alcohol Use Disorder Pipeline 2026: Latest FDA Approvals, Clinical Trials, And Emerging Therapies Assessment By Delveinsight Alkermes, Teva Pharma, Biocorrx, Inc., Adial Pharma, ADDEX THERAPEUTICS - Mena FN
Fund Flows: Whats the beta of Adial Pharmaceuticals Inc stockCPI Data & Technical Entry and Exit Alerts - baoquankhu1.vn
Adial Pharmaceuticals to Present at Oppenheimer Conference - Intellectia AI
Adial Pharmaceuticals to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - Bitget
Litchfield Hills Research Estimates ADIL FY2025 Earnings - Defense World
ADIL Technical Analysis & ETF Price Forecast - Intellectia AI
Can Adial Pharmaceuticals Inc. outperform under higher oil pricesEarnings Growth Summary & Low Risk Entry Point Tips - mfd.ru
Buyback Watch: Whats the beta of Adial Pharmaceuticals Inc stockSell Signal & Community Consensus Picks - baoquankhu1.vn
Will Adial Pharmaceuticals Inc. stock benefit from commodity pricesJuly 2025 Chart Watch & High Accuracy Swing Trade Signals - mfd.ru
Will Adial Pharmaceuticals Inc. benefit from geopolitical trends2025 Macro Impact & Growth Focused Entry Point Reports - mfd.ru
Market Leaders: Whats the fair value of Adial Pharmaceuticals Inc stockJuly 2025 Catalysts & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Why did Adial Pharmaceuticals stock plunge over 20% after hours today? - MSN
Why Is Adial Pharmaceuticals Stock (ADIL) Down Today? - TipRanks
Key facts: Adial Pharmaceuticals to execute reverse stock split; supports FDA trial - TradingView
Dow Jumps Over 200 Points; Uber Shares Fall After Q4 Results - Benzinga
Adial Pharmaceuticals Commends Congressional Directive for Alternative Clinical Trial Endpoints in Substance Use Disorder Treatments - Quiver Quantitative
Adial Pharma To Effect 1 For 25 Reverse Stock Split To Regain Nasdaq Compliance; Shares Plunge - Nasdaq
Adial Applauds Congressional Directive Advancing Alternative Clinical Trial Endpoints for Substance Use Disorders, Strengthening Regulatory Path for AD04 - marketscreener.com
Super Micro Computer Q2 Earnings Exceed Expectations - Intellectia AI
Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
Why Did Adial Pharmaceuticals Stock Plunge Over 20% After Hours Today? - Menafn.com
Adial Pharmaceuticals Applauds New Legislation for Addiction Treatment - Intellectia AI
U.S. Stocks Mixed; Eli Lilly Shares Surge After Earnings Beat - Intellectia AI
Adial Pharmaceuticals stock tumbles after announcing 1-for-25 reverse split - Investing.com Nigeria
Adial Pharmaceuticals stock tumbles after announcing 1-for-25 reverse split By Investing.com - Investing.com South Africa
Adial Pharmaceuticals (ADIL) Announces 1-for-25 Reverse Stock Sp - GuruFocus
Adial Pharmaceuticals announces 1-for-25 reverse stock split By Investing.com - Investing.com India
Adial Pharmaceuticals Announces Reverse Stock Split - citybiz
Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement - The Manila Times
Adial Pharmaceuticals announces 1-for-25 reverse stock split - Investing.com
Adial Pharmaceuticals Announces Reverse Stock Split to - GlobeNewswire
Retail Trends: Is Adial Pharmaceuticals Inc affected by consumer sentimentStop Loss & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Down 24.9% in January - Defense World
Trading Recap: Will Adial Pharmaceuticals Inc benefit from government policy2025 EndofYear Setup & High Conviction Buy Zone Picks - baoquankhu1.vn
Performance Recap: What is Bit Digital Incs market positionWeekly Trend Summary & Free High Return Stock Watch Alerts - baoquankhu1.vn
Aug Shorts: Does TELO have declining or rising EPSStock Surge & AI Enhanced Execution Alerts - baoquankhu1.vn
Aug Mood: How sensitive is FS Bancorp Inc to inflationQuarterly Portfolio Report & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Adial Pharmaceuticals Inc Stock (ADIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.20%
0.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):